19-44613740-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001205280.2(IGSF23):c.95C>A(p.Ala32Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000838 in 1,550,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001205280.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGSF23 | NM_001205280.2 | c.95C>A | p.Ala32Glu | missense_variant | 1/5 | ENST00000402988.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGSF23 | ENST00000402988.6 | c.95C>A | p.Ala32Glu | missense_variant | 1/5 | 3 | NM_001205280.2 | P1 | |
CEACAM22P | ENST00000455455.1 | n.57+7025G>T | intron_variant, non_coding_transcript_variant | 4 | |||||
IGSF23 | ENST00000592507.1 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000671 AC: 1AN: 148942Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 80200
GnomAD4 exome AF: 0.00000215 AC: 3AN: 1398240Hom.: 0 Cov.: 33 AF XY: 0.00000145 AC XY: 1AN XY: 689644
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2023 | The c.95C>A (p.A32E) alteration is located in exon 1 (coding exon 1) of the IGSF23 gene. This alteration results from a C to A substitution at nucleotide position 95, causing the alanine (A) at amino acid position 32 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at